— Know what they know.
Not Investment Advice
Also trades as: 5EA.DE (XETRA) · $vol 0M

ELAN NYSE

Elanco Animal Health Incorporated
1W: -0.3% 1M: +0.8% 3M: -14.2% YTD: +0.5% 1Y: +2.7% 3Y: +147.2% 5Y: -30.6%
$22.65
-0.31 (-1.35%)
 
Weekly Expected Move ±3.8%
$21 $22 $23 $23 $24
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 51 · $11.3B mcap · 495M float · 1.17% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 51% of companies Debt: 25.7% of company value Bonds: $41.9M held by 70 funds, 126 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.65 (down 97%), Elanco Animal Health Incorporated would be worth roughly what it owes.
Total debt $3.92B against a stock market value of $11.31B.
Distance to default 5.20 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.00B (short-term plus half of long-term), stock volatility 42.0%; Altman Z 1.32. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 3.7%  ·  5Y Avg: -1.1%
Cost Advantage
52
Intangibles
63
Switching Cost
32
Network Effect
55
Scale
63
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ELAN shows a Weak competitive edge (51.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 3.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$24
Low
$27
Avg Target
$30
High
Based on 2 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 5Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$27.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-20 Jefferies — Initiated $24 — +2.2% $23.49
2026-08-06 KeyBanc — $29 $30 +1 +14.4% $26.22
2026-07-22 Morgan Stanley Erin Wright $23 $26 +3 +1.2% $25.70
2026-05-15 Morgan Stanley — $22 $23 +1 +9.9% $20.92
2026-02-25 KeyBanc Steve Dechert $27 $29 +2 +6.9% $27.13
2026-02-24 Leerink Partners Daniel Clark $11 $30 +19 +13.8% $26.37
2026-01-29 UBS — $25 $30 +5 +24.1% $24.17
2026-01-22 Piper Sandler David Westenberg $12 $30 +18 +23.5% $24.30
2025-12-18 Morgan Stanley — $37 $22 -15 -0.4% $22.08
2025-12-08 Barclays — $22 $30 +8 +38.3% $21.69
2025-11-20 KeyBanc — Initiated $27 — +25.8% $21.46
2025-11-19 Argus Research — Initiated $25 — +16.5% $21.46
2025-11-05 Stifel Nicolaus — $20 $27 +7 +23.3% $21.91
2025-10-20 UBS — $19 $25 +6 +15.5% $21.64
2025-08-08 UBS Andrea Alfonso $18 $19 +1 +14.0% $16.67
2025-07-17 J.P. Morgan Rajat Gupta $32 $14 -18 -5.3% $14.79
2025-05-07 Leerink Partners Daniel Clark $14 $11 -3 +15.7% $9.51
2025-03-06 Piper Sandler — $16 $12 -4 +10.8% $10.83
2024-12-09 UBS Andrea Alfonso Initiated $18 — +44.0% $12.50
2024-12-02 Leerink Partners Daniel Clark Initiated $14 — +6.4% $13.16
2024-09-23 Barclays Balaji Prasad $18 $22 +4 +56.4% $14.07
2024-07-01 Piper Sandler David Westenberg $19 $16 -3 +10.9% $14.43
2024-05-13 Piper Sandler David Westenberg $18 $19 +1 +11.8% $17.00
2024-03-12 Piper Sandler David Westenberg $21 $18 -3 +14.1% $15.77
2024-01-05 Stifel Nicolaus Jonathan Block $22 $20 -2 +29.4% $15.45
2022-09-12 Barclays — Initiated $18 — +20.0% $15.00
2022-08-16 Piper Sandler David Westenberg Initiated $21 — +10.1% $19.08
2022-07-18 J.P. Morgan — Initiated $32 — +58.9% $20.14
2022-06-24 Stifel Nicolaus — Initiated $22 — +10.3% $19.94
2022-05-19 Goldman Sachs — Initiated $32 — +37.0% $23.35
2022-05-17 Morgan Stanley — Initiated $37 — +55.9% $23.73

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ELAN receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-09-11 C C-
2026-09-08 C- C
2026-09-02 C C-
2026-08-04 C- C
2026-07-27 C C-
2026-05-26 C- C
2026-05-06 C C-
2026-05-05 C- C
2026-03-03 C C-
2026-02-27 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 26 Grade C
Profitability
25
Balance Sheet
42
Earnings Quality
48
Growth
42
Value
39
Momentum
42
Safety
30
Cash Flow
41
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ELAN scores highest in Earnings Quality (48/100) and lowest in Profitability (25/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.42
Distress Zone
Piotroski F-Score
5/9
✗ ✓ ✗ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-2.85
Unlikely Manipulator
Ohlson O-Score
-7.49
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB-
Score: 35.1/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -3.10x
Accruals: -6.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ELAN scores 1.42, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ELAN scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ELAN's score of -2.85 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ELAN's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ELAN receives an estimated rating of BB- (score: 35.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-55.24x
PEG
0.35x
P/S
2.25x
P/B
1.72x
P/FCF
32.85x
P/OCF
20.18x
EV/EBITDA
20.46x
EV/Revenue
3.16x
EV/EBIT
195.53x
EV/FCF
41.79x
Earnings Yield
-1.60%
FCF Yield
3.04%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ELAN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.199
NI / EBT
×
Interest Burden
-2.049
EBT / EBIT
×
EBIT Margin
0.016
EBIT / Rev
×
Asset Turnover
0.368
Rev / Assets
×
Equity Multiplier
2.043
Assets / Equity
=
ROE
-3.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ELAN's ROE of -3.0% is driven by Asset Turnover (0.368), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.20 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$22.64
Median 1Y
$20.12
5th Pctile
$9.81
95th Pctile
$41.24
Ann. Volatility
45.1%
Analyst Target
$27.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Todd Young Financial
ecutive Vice President and Chief Financial Officer
$477,096 $2,175,000 $4,754,889

CEO Pay Ratio

98:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,833,704
Avg Employee Cost (SGA/emp): $152,128
Employees: 9,400

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
9,400
+4.4% YoY
Revenue / Employee
$501,596
Rev: $4,715,000,000
Profit / Employee
$-24,681
NI: $-232,000,000
SGA / Employee
$152,128
Avg labor cost proxy
R&D / Employee
$39,149
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -8.7% -6.0% -4.7% -2.2% -1.8% -1.1% -0.3% -1.6% -17.8% -18.2% -19.2% -18.8% 3.2% 5.5% 6.0% 6.8% 0.5% -3.7% -3.8% -3.0% -2.98%
ROA -4.1% -2.8% -2.2% -1.0% -0.8% -0.5% -0.2% -0.7% -7.8% -8.2% -8.7% -8.5% 1.5% 2.5% 2.8% 3.2% 0.3% -1.8% -1.8% -1.5% -1.46%
ROIC 0.9% 1.8% 2.3% 2.5% 2.6% 2.4% 2.6% 2.1% 2.3% 2.2% 1.6% 2.1% 1.2% 1.7% 1.6% 1.5% 1.9% 2.0% 3.4% 3.7% 3.66%
ROCE -2.6% -1.2% -1.0% 0.5% 1.2% 1.3% 1.6% 1.3% -6.5% -6.7% -7.7% -7.9% 5.8% 6.8% 6.9% 7.0% 1.8% 0.4% 0.6% 0.7% 0.69%
Gross Margin 43.1% 41.5% 47.3% 47.5% 41.5% 41.5% 50.0% 46.1% 41.3% 36.8% 46.2% 47.1% 39.3% 38.1% 46.6% 46.5% 53.4% 39.3% 57.3% 58.3% 58.33%
Operating Margin 4.6% 3.9% 14.4% 11.3% 4.9% 2.7% 17.6% 5.0% 3.9% 1.0% 11.0% 9.7% -0.5% 0.8% 10.1% 6.8% 2.4% 1.7% 22.4% 8.0% 7.97%
Net Margin -9.2% -9.3% 4.2% -0.9% -6.3% -5.5% 8.2% -9.2% -1.0% -13.6% 2.7% -4.2% 35.3% -0.8% 5.6% 0.9% -3.0% -24.1% 4.2% 3.9% 3.95%
EBITDA Margin 8.8% 12.4% 25.0% 19.1% 17.8% 14.8% 27.8% 19.0% -79.8% 10.7% 20.2% 16.5% 79.0% 17.2% 23.0% 21.3% 15.7% 0.5% 23.0% 20.0% 20.03%
FCF Margin -1.8% 6.0% 4.9% 8.3% 10.3% 6.1% 3.9% -2.0% -1.5% 2.6% 6.4% 9.5% 8.5% 8.7% 7.7% 7.9% 7.9% 6.0% 6.4% 7.5% 7.55%
OCF Margin 3.5% 10.1% 8.4% 12.1% 14.6% 10.2% 8.3% 2.7% 2.9% 6.1% 9.6% 12.4% 11.7% 12.2% 12.1% 12.8% 13.7% 11.9% 11.8% 12.3% 12.29%
ROE 3Y Avg snapshot only -5.91%
ROE 5Y Avg snapshot only -4.32%
ROA 3Y Avg snapshot only -2.48%
ROIC 3Y Avg snapshot only -0.56%
ROIC Economic snapshot only 3.51%
Cash ROA snapshot only 4.55%
Cash ROIC snapshot only 6.18%
CROIC snapshot only 3.80%
NOPAT Margin snapshot only 7.27%
Pretax Margin snapshot only -3.31%
R&D / Revenue snapshot only 7.39%
SGA / Revenue snapshot only 30.26%
SBC / Revenue snapshot only 1.47%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -22.27 -28.88 -34.99 -57.41 -47.35 -76.53 -178.17 -43.85 -4.84 -5.96 -6.20 -5.68 35.66 17.71 14.05 16.45 277.93 -48.47 -50.04 -62.56 -55.244
P/S Ratio 3.24 2.90 2.70 2.06 1.34 1.35 1.04 1.14 1.27 1.66 1.85 1.59 1.64 1.35 1.18 1.59 2.18 2.38 2.47 2.48 2.253
P/B Ratio 2.02 1.84 1.69 1.34 0.90 0.82 0.62 0.67 0.90 1.18 1.33 1.20 1.12 0.98 0.82 1.05 1.48 1.72 1.86 1.89 1.717
P/FCF -181.12 48.37 55.35 24.77 13.01 22.27 26.78 -56.96 -85.20 62.76 29.05 16.78 19.24 15.43 15.37 20.12 27.64 39.59 38.44 32.85 32.850
P/OCF 93.00 28.64 32.18 17.06 9.16 13.21 12.55 42.00 43.61 27.09 19.32 12.80 14.03 11.07 9.80 12.49 15.91 20.08 20.99 20.18 20.179
EV/EBITDA 58.32 36.14 34.19 19.69 13.50 13.33 11.44 12.12 -71.01 -66.83 -45.59 -41.03 8.20 6.89 6.27 7.08 15.18 20.38 20.51 20.46 20.463
EV/Revenue 4.47 4.10 3.92 3.26 2.53 2.60 2.32 2.46 2.53 2.89 3.09 2.76 2.51 2.22 2.07 2.41 2.95 3.12 3.20 3.16 3.155
EV/EBIT -53.97 -110.87 -128.51 194.14 70.13 64.75 46.34 55.18 -13.06 -14.42 -13.73 -12.72 16.08 12.85 11.42 12.53 61.20 350.40 214.68 195.53 195.533
EV/FCF -249.66 68.23 80.32 39.13 24.68 42.76 59.74 -122.42 -170.43 109.10 48.54 29.16 29.42 25.36 26.83 30.45 37.36 51.82 49.75 41.79 41.789
Earnings Yield -4.5% -3.5% -2.9% -1.7% -2.1% -1.3% -0.6% -2.3% -20.7% -16.8% -16.1% -17.6% 2.8% 5.6% 7.1% 6.1% 0.4% -2.1% -2.0% -1.6% -1.60%
FCF Yield -0.6% 2.1% 1.8% 4.0% 7.7% 4.5% 3.7% -1.8% -1.2% 1.6% 3.4% 6.0% 5.2% 6.5% 6.5% 5.0% 3.6% 2.5% 2.6% 3.0% 3.04%
PEG Ratio snapshot only 0.349
EV/OCF snapshot only 25.670
EV/Gross Profit snapshot only 5.999
Acquirers Multiple snapshot only 34.282
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.32 1.99 2.44 2.47 1.96 1.93 2.25 2.84 2.82 2.75 3.29 2.93 2.55 2.44 2.71 2.60 2.40 2.17 2.16 2.05 2.050
Quick Ratio 1.30 1.16 1.41 1.47 1.12 1.02 1.24 1.53 1.48 1.35 1.96 1.75 1.31 1.25 1.46 1.40 1.23 1.08 1.12 1.10 1.095
Debt/Equity 0.82 0.84 0.81 0.85 0.87 0.80 0.80 0.82 0.96 0.93 0.95 0.96 0.67 0.71 0.69 0.62 0.60 0.61 0.61 0.59 0.595
Net Debt/Equity 0.77 0.76 0.76 0.78 0.81 0.75 0.76 0.77 0.90 0.87 0.89 0.89 0.59 0.63 0.62 0.54 0.52 0.53 0.55 0.51 0.514
Debt/Assets 0.38 0.38 0.38 0.39 0.39 0.38 0.38 0.38 0.41 0.40 0.41 0.41 0.33 0.34 0.34 0.31 0.30 0.30 0.30 0.29 0.289
Debt/EBITDA 17.24 11.70 11.26 7.88 6.93 6.79 6.67 6.90 -37.88 -30.23 -19.48 -18.79 3.19 3.03 3.01 2.76 4.52 5.56 5.22 5.06 5.062
Net Debt/EBITDA 16.01 10.52 10.63 7.22 6.39 6.38 6.31 6.48 -35.51 -28.39 -18.31 -17.42 2.84 2.70 2.68 2.40 3.95 4.81 4.66 4.38 4.377
Interest Coverage -1.08 -0.45 -0.55 0.29 0.62 0.71 0.85 0.65 -2.75 -2.85 -3.19 -3.61 2.46 2.76 3.02 3.20 0.93 0.16 0.27 0.31 0.313
Equity Multiplier 2.16 2.19 2.13 2.19 2.22 2.13 2.11 2.13 2.34 2.31 2.31 2.32 2.04 2.07 2.04 2.03 2.01 2.04 2.03 2.06 2.058
Cash Ratio snapshot only 0.286
Debt Service Coverage snapshot only 2.988
Cash to Debt snapshot only 0.135
FCF to Debt snapshot only 0.097
Defensive Interval snapshot only 281.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.28 0.28 0.29 0.29 0.29 0.28 0.28 0.28 0.30 0.30 0.29 0.30 0.32 0.33 0.33 0.33 0.34 0.36 0.37 0.37 0.368
Inventory Turnover 1.88 1.82 1.89 1.84 1.85 1.68 1.65 1.57 1.59 1.51 1.55 1.55 1.54 1.53 1.56 1.56 1.47 1.53 1.50 1.38 1.384
Receivables Turnover 5.68 5.59 4.75 4.68 5.25 5.42 4.39 4.52 5.10 5.39 4.28 4.49 5.09 5.39 4.52 4.51 5.30 5.40 4.76 4.86 4.860
Payables Turnover 7.07 5.87 6.45 5.73 6.40 6.06 6.19 6.42 7.44 7.51 7.32 7.92 9.20 8.94 7.97 7.76 8.06 7.61 7.05 5.99 5.987
DSO 64 65 77 78 69 67 83 81 72 68 85 81 72 68 81 81 69 68 77 75 75.1 days
DIO 194 200 193 199 198 217 222 232 230 241 236 236 237 239 234 234 248 239 244 264 263.7 days
DPO 52 62 57 64 57 60 59 57 49 49 50 46 40 41 46 47 45 48 52 61 61.0 days
Cash Conversion Cycle 207 203 213 213 210 225 246 256 253 260 272 271 270 266 269 268 271 259 269 278 277.9 days
Fixed Asset Turnover snapshot only 3.558
Operating Cycle snapshot only 338.8 days
Cash Velocity snapshot only 9.472
Capital Intensity snapshot only 2.701
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 64.1% 45.6% 23.1% 2.1% -5.3% -7.3% -6.4% -6.8% -3.7% 0.0% -1.8% 3.8% 1.9% 0.5% 1.4% -0.2% 3.1% 6.2% 10.5% 12.0% 11.95%
Net Income -1.8% 14.5% 35.8% 77.1% 81.7% 83.7% 92.9% 32.3% -7.9% -14.8% -49.1% -10.1% 1.2% 1.3% 1.3% 1.3% -82.4% -1.7% -1.6% -1.5% -1.46%
EPS -1.7% 14.7% 36.6% 77.1% 81.7% 83.8% 92.9% 32.9% -7.9% -14.6% -48.8% -10.1% 1.2% 1.3% 1.3% 1.3% -82.4% -1.7% -1.6% -1.5% -1.45%
FCF 11.7% 1.8% 1.7% 2.1% 6.4% -6.3% -25.4% -1.2% -1.1% -56.3% 60.7% 5.9% 6.8% 2.3% 22.7% -16.5% -4.7% -26.8% -7.6% 6.8% 6.76%
EBITDA 1.7% 336.5% 1.0% 2.2% 1.3% 59.3% 65.7% 14.3% -1.2% -1.2% -1.3% -1.3% 9.7% 8.5% 5.9% 6.1% -34.7% -49.4% -47.6% -49.3% -49.31%
Op. Income 50.2% 5.0% 32.5% 3.6% 1.6% 27.0% 10.2% -13.1% -14.7% -15.5% -44.8% -14.5% -26.2% -23.0% 0.4% -30.3% -4.7% 0.4% 83.3% 1.2% 1.21%
OCF Growth snapshot only 7.87%
Asset Growth snapshot only -1.32%
Equity Growth snapshot only -2.76%
Debt Growth snapshot only -6.91%
Shares Change snapshot only 1.16%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 84.6% 45.1% 27.5% 14.8% 13.8% 12.9% 14.0% 15.6% 14.4% 10.5% 4.2% -0.4% -2.4% -2.3% -2.3% -1.2% 0.4% 2.2% 3.2% 5.1% 5.07%
Revenue 5Y — — — — — — — — 41.8% 23.1% 13.8% 7.9% 7.6% 7.6% 8.1% 9.9% 9.5% 7.6% 4.9% 2.0% 1.98%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — 10.4% 30.4% — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — 16.9% 37.9% — — — — — — —
EBITDA 3Y 34.3% 30.3% 11.5% 13.0% 22.3% 22.2% 36.0% 52.6% — — — — 54.9% 38.3% 38.8% 25.7% 1.5% -5.7% -5.4% -4.2% -4.15%
EBITDA 5Y — — — — — — — — — — — — 23.9% 24.8% 32.3% 43.9% 46.0% 2.4% 23.5% 26.5% 26.53%
Gross Profit 3Y 79.8% 45.1% 27.9% 14.4% 12.8% 12.1% 14.8% 17.6% 18.2% 15.8% 7.6% 1.4% -1.6% -2.7% -3.6% -2.6% 1.7% 3.5% 6.1% 10.6% 10.59%
Gross Profit 5Y — — — — — — — — 41.8% 23.3% 12.9% 6.8% 6.1% 6.4% 7.4% 9.9% 12.3% 11.9% 10.0% 7.3% 7.29%
Op. Income 3Y 13.7% 15.9% 10.7% 0.8% 1.2% 1.4% 12.6% 17.9% 49.6% — — 50.3% 18.0% -6.2% -15.1% -19.7% -15.7% -13.2% 0.5% 9.6% 9.59%
Op. Income 5Y — — — — — — — — 26.8% 10.8% -3.8% -5.3% -8.2% -7.5% -4.5% -0.5% 18.6% — — 39.2% 39.20%
FCF 3Y — 8.3% 4.6% 18.6% 72.3% 1.2% 1.7% — — — — — — 10.7% 13.7% -2.8% -8.1% 2.0% 22.1% — —
FCF 5Y — — — — — — — — — -12.3% 6.5% 12.9% 33.1% 70.8% 1.1% 23.4% — — — — —
OCF 3Y 0.6% 16.8% 8.9% 15.8% 40.8% 26.3% 18.3% -29.0% -10.7% — — — 46.1% 3.9% 10.3% 0.6% -1.7% 7.4% 16.1% 73.6% 73.57%
OCF 5Y — — — — — — — — -5.0% -2.2% 6.2% 9.0% 17.0% 19.3% 19.1% 11.7% 28.7% — — — —
Assets 3Y 21.6% 22.5% 22.9% 20.8% 19.2% 19.9% 17.5% 16.9% -5.9% -6.7% -6.2% -6.5% -7.1% -8.5% -7.3% -4.1% -3.2% -4.8% -5.7% -5.0% -4.96%
Assets 5Y — — — — — — — — 9.3% 9.9% 9.9% 9.2% 8.5% 7.0% 5.9% 6.8% -4.7% -5.5% -4.9% -4.2% -4.23%
Equity 3Y 14.4% 13.0% 13.6% 10.7% 7.1% 9.5% 3.9% 3.7% -9.7% -9.8% -8.9% -9.4% -5.3% -6.7% -5.8% -1.7% 0.0% -3.5% -4.6% -3.9% -3.89%
Book Value 3Y 3.9% 2.7% 2.9% 0.6% -2.1% 0.3% -2.7% -2.2% -11.6% -10.2% -9.5% -9.8% -6.0% -7.2% -6.3% -2.5% -0.5% -4.1% -5.4% -4.7% -4.74%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.87 0.93 1.00 0.75 0.69 0.73 0.77 0.49 0.80 0.79 0.72 0.57 0.46 0.49 0.48 0.60 0.69 0.81 0.84 0.31 0.308
Earnings Stability 0.85 0.74 0.67 0.30 0.33 0.20 0.12 0.08 0.62 0.54 0.49 0.44 0.03 0.00 0.00 0.01 0.11 0.09 0.06 0.09 0.093
Margin Stability 0.94 0.92 0.93 0.95 0.95 0.92 0.93 0.95 0.95 0.94 0.94 0.96 0.96 0.98 0.97 0.97 0.95 0.93 0.91 0.90 0.899
Rev. Growth Consistency 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 0.00 1.00 1.00 1.00 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.86 0.50 0.50 0.50 0.50 0.87 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — 0.00 — — — —
ROE Trend -0.08 -0.04 -0.01 0.03 0.04 0.05 0.06 0.04 -0.13 -0.16 -0.19 -0.19 0.13 0.16 0.17 0.18 0.08 0.04 0.04 0.04 0.043
Gross Margin Trend -0.02 0.02 0.03 0.03 0.03 0.04 0.04 0.02 0.02 -0.00 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 0.03 0.03 0.07 0.10 0.095
FCF Margin Trend -0.02 0.11 0.09 0.10 0.13 0.08 0.06 -0.02 -0.06 -0.03 0.02 0.06 0.04 0.04 0.03 0.04 0.04 0.00 -0.01 -0.01 -0.011
Sustainable Growth Rate — — — — — — — — — — — — 3.2% 5.5% 6.0% 6.8% 0.5% — — — —
Internal Growth Rate — — — — — — — — — — — — 1.5% 2.6% 2.8% 3.3% 0.3% — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.24 -1.01 -1.09 -3.37 -5.17 -5.79 -14.19 -1.04 -0.11 -0.22 -0.32 -0.44 2.54 1.60 1.43 1.32 17.47 -2.41 -2.38 -3.10 -3.101
FCF/OCF -0.51 0.59 0.58 0.69 0.70 0.59 0.47 -0.74 -0.51 0.43 0.67 0.76 0.73 0.72 0.64 0.62 0.58 0.51 0.55 0.61 0.614
FCF/Net Income snapshot only -1.905
OCF/EBITDA snapshot only 0.797
CapEx/Revenue 5.3% 4.1% 3.5% 3.8% 4.3% 4.2% 4.4% 4.7% 4.4% 3.5% 3.2% 2.9% 3.2% 3.4% 4.4% 4.8% 5.8% 5.9% 5.4% 4.7% 4.74%
CapEx/Depreciation snapshot only 0.343
Accruals Ratio -0.05 -0.06 -0.05 -0.04 -0.05 -0.03 -0.02 -0.01 -0.09 -0.10 -0.12 -0.12 -0.02 -0.02 -0.01 -0.01 -0.04 -0.06 -0.06 -0.06 -0.060
Sloan Accruals snapshot only -0.071
Cash Flow Adequacy snapshot only 2.592
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% — — — —
FCF Payout Ratio — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.91 0.85 0.90 0.89 1.25 1.10 0.68 1.10 0.99 1.03 1.01 1.01 0.50 0.69 0.70 0.73 -2.25 1.04 1.23 1.20 1.199
Interest Burden (EBT/EBIT) 1.93 3.21 2.83 -2.41 -0.62 -0.40 -0.17 -0.53 1.36 1.35 1.31 1.28 0.59 0.64 0.67 0.69 -0.07 -5.33 -2.70 -2.05 -2.049
EBIT Margin -0.08 -0.04 -0.03 0.02 0.04 0.04 0.05 0.04 -0.19 -0.20 -0.23 -0.22 0.16 0.17 0.18 0.19 0.05 0.01 0.01 0.02 0.016
Asset Turnover 0.28 0.28 0.29 0.29 0.29 0.28 0.28 0.28 0.30 0.30 0.29 0.30 0.32 0.33 0.33 0.33 0.34 0.36 0.37 0.37 0.368
Equity Multiplier 2.11 2.14 2.13 2.15 2.18 2.16 2.12 2.16 2.27 2.21 2.20 2.21 2.18 2.19 2.17 2.16 2.02 2.05 2.04 2.04 2.043
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.43 $-0.98 $-0.75 $-0.34 $-0.26 $-0.16 $-0.05 $-0.23 $-2.32 $-2.50 $-2.62 $-2.54 $0.41 $0.68 $0.75 $0.87 $0.07 $-0.47 $-0.48 $-0.39 $-0.39
Book Value/Share $15.76 $15.40 $15.47 $14.62 $13.81 $14.92 $15.18 $15.06 $12.45 $12.63 $12.21 $12.02 $13.11 $12.33 $12.73 $13.55 $13.58 $13.18 $12.85 $13.02 $13.19
Tangible Book/Share $-8.88 $-8.72 $-7.92 $-7.82 $-7.65 $-7.26 $-6.84 $-6.70 $-6.58 $-6.83 $-5.28 $-5.14 $-4.25 $-4.04 $-3.58 $-3.38 $-3.24 $-3.30 $-2.86 $-2.89 $-2.89
Revenue/Share $9.83 $9.78 $9.65 $9.51 $9.30 $9.04 $9.02 $8.79 $8.87 $8.96 $8.80 $9.09 $8.95 $8.98 $8.87 $8.97 $9.24 $9.49 $9.67 $9.92 $10.05
FCF/Share $-0.18 $0.59 $0.47 $0.79 $0.95 $0.55 $0.35 $-0.18 $-0.13 $0.24 $0.56 $0.86 $0.76 $0.78 $0.68 $0.71 $0.73 $0.57 $0.62 $0.75 $0.76
OCF/Share $0.34 $0.99 $0.81 $1.15 $1.36 $0.93 $0.75 $0.24 $0.26 $0.55 $0.84 $1.13 $1.05 $1.09 $1.07 $1.14 $1.27 $1.13 $1.14 $1.22 $1.24
Cash/Share $0.93 $1.31 $0.69 $1.04 $0.94 $0.71 $0.65 $0.75 $0.75 $0.71 $0.70 $0.84 $0.98 $0.95 $0.98 $1.08 $1.02 $1.10 $0.85 $1.05 $1.06
EBITDA/Share $0.75 $1.11 $1.11 $1.57 $1.74 $1.76 $1.83 $1.78 $-0.32 $-0.39 $-0.60 $-0.61 $2.74 $2.89 $2.92 $3.05 $1.79 $1.45 $1.51 $1.53 $1.53
Debt/Share $13.00 $12.96 $12.46 $12.41 $12.08 $11.95 $12.22 $12.31 $11.99 $11.72 $11.62 $11.49 $8.75 $8.74 $8.81 $8.42 $8.10 $8.08 $7.89 $7.74 $7.74
Net Debt/Share $12.07 $11.66 $11.77 $11.38 $11.14 $11.24 $11.57 $11.56 $11.24 $11.00 $10.93 $10.64 $7.77 $7.79 $7.83 $7.34 $7.08 $6.99 $7.04 $6.70 $6.70
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.419
Altman Z-Prime snapshot only 2.358
Piotroski F-Score 5 6 6 6 3 4 4 5 3 4 4 5 6 7 7 5 7 5 5 5 5
Beneish M-Score -2.51 -2.90 -2.70 -2.76 -2.79 -2.69 -2.60 -2.46 -2.84 -2.92 -3.24 -3.26 -2.80 -2.75 -2.58 -2.52 -2.76 -2.72 -2.79 -2.85 -2.847
Ohlson O-Score snapshot only -7.489
Net-Net WC snapshot only $-6.28
EVA snapshot only $-632620000.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 26.90 26.44 28.27 28.44 28.28 27.38 28.41 29.35 35.37 35.19 36.71 37.15 42.16 41.24 45.47 46.20 35.73 34.16 34.45 35.08 35.080
Credit Grade snapshot only 13
Credit Trend snapshot only -11.124
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 25
Sector Credit Rank snapshot only 27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms